GUTI: A new antigen in the Cromer blood group system

Transfusion

Volumn 43, Issue 3, 2003, Pages 340-344

  Storry, Jill R ^b   Sausais, Laima ^b   Hue Roye, Kim ^b   Mudiwa, Flora ^b   Ferrer, Zennie ^b   Blajchman, Morris A ^b   Lublin, Douglas M ^b   Ma, Bei Wen ^b   Miquel, Juan F ^b   Nervi, Flavio ^b   Pereira, Jaime ^b   Reid, Marion E ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD GROUP GUTI ANTIGEN; COMPLEMENTARY DNA; EPITOPE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD GROUP CROMER SYSTEM; BLOOD GROUP SYSTEM; CASE REPORT; DELETION MUTANT; HUMAN; IMMUNOBLOTTING; MALE; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD55; BLOOD GROUP ANTIGENS; CHILE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, COMPLEMENTARY; ERYTHROCYTE MEMBRANE; GENE DELETION; HUMANS; ISOANTIBODIES; ISOANTIGENS; MALE; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0037342364     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00319.x     Document Type: Article

References (16)

1. Daniels G. Cromer-related antigens. Blood group determinants on decay-accelerating factor. Vox Sang 1989;56:205-11.
2. Lublin DM, Atkinson JP. Decay-accelerating factor. Biochemistry, molecular biology and function. Ann Rev Immunol 1989;7:35-58.
3. Daniels GL, Anstee DJ, Cartron JP, et al. Blood group terminology 1995. ISBT working party on terminology for red cell surface antigens. Vox Sang 1995;69:265-79.
4. a epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84:3205-11.
5. Lublin DM, Kompelli S, Storry JR, Reid ME. Molecular basis of Cromer blood group antigens. Transfusion 2000;40:208-13.
6. b on decay-accelerating factor. Transfusion 1995;35:278.
7. Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276-82.
8. Telen MJ, Rosse WF, Parker CJ, et al. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins. Blood 1990;75:1404-7.
9. Huang CH, Reid ME, Blumenfeld OO. Remodeling of the transmembrane segment in human glycophorin by aberrant RNA splicing. J Biol Chem 1994;269:10804-12.
10. Coyne KE, Hall SE, Thompson S, et al. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 1992;149:2906-13.
11. a. Transfusion 1984;24:13-5.
12. a and a family with the Dr (a-) phenotype in two generations. Transfusion 1987;27:64-5.
13. Reid ME, Mallinson G, Sim RB, et al. Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency). Blood 1991;78:3291-7.
14. Daniels GL, Okubo Y, Yamaguchi H, et al. UMC, another Cromer-related blood group antigen. Transfusion 1989;29:794-7.
15. Uchikawa M, Tsuneyama H, Wang L, et al. Rare Cromer blood group phenotypes detected in Japanese (abstract). In: 24th Congress of the International Society of Blood Transfusion ISBT '96 Abstracts, Makuhari Messe, Japan, 1996;143.
16. Daniels GL, Green CA, Mallinson G, et al. Decay-accelerating factor (CD55) deficiency phenotypes in Japanese. Transfus Med 1998;8:141-7.